Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease

Emanuele Di Angelantonio, Pei Gao, Hassan Khan, Adam S. Butterworth, David Wormser, Stephen Kaptoge, Sreenivasa Rao Kondapally Seshasai, Alex Thompson, Nadeem Sarwar, Peter Willeit, Paul M. Ridker, Elizabeth L. M. Barr, Kay-Tee Khaw, Bruce M. Psaty, Hermann Brenner, Beverley Balkau, Jacqueline M. Dekker, Debbie A. Lawlor, Makoto Daimon, Johann WilleitInger Njolstad, Aulikki Nissinen, Eric J. Brunner, Lewis H. Kuller, Jackie F. Price, Johan Sundstrom, Matthew W. Knuiman, Edith J. M. Feskens, W. M. M. Verschuren, Nicholas Wald, Stephan J. L. Bakker, Peter H. Whincup, Ian Ford, Uri Goldbourt, Agustin Gomez-de-la-Camara, John Gallacher, Leon A. Simons, Annika Rosengren, Susan E. Sutherland, Cecilia Bjorkelund, Dan G. Blazer, Sylvia Wassertheil-Smoller, Altan Onat, Alejandro Marin Ibanez, Edoardo Casiglia, J. Wouter Jukema, Lara M. Simpson, Simona Giampaoli, Borge G. Nordestgaard, Randi Selmer, Patrik Wennberg, Jussi Kauhanen, Jukka T. Salonen, Rachel Dankner, Elizabeth Barrett-Connor, Maryam Kavousi, Vilmundur Gudnason, Denis Evans, Robert B. Wallace, Mary Cushman, Ralph B., Sr. D'Agostino, Jason G. Umans, Yutaka Kiyohara, Hidaeki Nakagawa, Shinichi Sato, Richard F. Gillum, Aaron R. Folsom, Yvonne T. van der Schouw, Karel G. Moons, Simon J. Griffin, Naveed Sattar, Nicholas J. Wareham, Elizabeth Selvin, Simon G. Thompson, Emerging Risk Factors Collaboration, Coen Stehouwer, John Danesh*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The value of measuring levels of glycated hemoglobin (HbA1c) for the prediction of first cardiovascular events is uncertain.To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk.Analysis of individual-participant data available from 73 prospective studies involving 294,998 participants without a known history of diabetes mellitus or CVD at the baseline assessment.Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (
Original languageEnglish
Pages (from-to)1225-1233
JournalJAMA-Journal of the American Medical Association
Volume311
Issue number12
DOIs
Publication statusPublished - 26 Mar 2014

Fingerprint

Dive into the research topics of 'Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this